Mortality by cause for eight regions of the world: Global Burden of Disease Study, The Lancet, vol.349, issue.9061, pp.1269-76, 1997. ,
DOI : 10.1016/S0140-6736(96)07493-4
Preventing stroke: saving lives around the world, The Lancet Neurology, vol.6, issue.2 ,
DOI : 10.1016/S1474-4422(07)70031-5
Oxford Vascular Study, Rothwell. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)Lancet, pp.1773-85, 2005. ,
Contribution of the Dijon Stroke Registry after 20 years of data collection, Rev Neurol Feb, vol.164, issue.2, pp.138-185, 2008. ,
American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics ? 2011 update: a report from the American Heart Association, Circulation. Feb, vol.1123, issue.4, pp.18-209, 2011. ,
Treatment and secondary prevention of stroke, The Lancet, vol.355, issue.9200, pp.1457-63, 1999. ,
DOI : 10.1016/S0140-6736(05)72320-5
Recommandations pour les unités neurovasculaires, Presse Med, vol.29, pp.2240-2248, 2000. ,
PF3 no 2012-106 du 6 mars 2012 relative à l'organisation des filières régionales de prise en charge des patients victimes d'accident vasculaire cérébral (AVC) Ministère du travail, de l'emploi et de la santé ,
Rehabilitation Programs, Cerebral Vascular Disease Transactions of the Second Conference of the American Heart Association ,
Stroke rehabilitation units: concepts, evaluation, and unresolved issues, Stroke, vol.16, issue.2, pp.178-81, 1985. ,
DOI : 10.1161/01.STR.16.2.178
URL : http://stroke.ahajournals.org/content/strokeaha/16/2/178.full.pdf
Filières de soins, unités d'urgences cérébrovasculaires, Rev Neurol, vol.155, pp.666-675, 1999. ,
Stroke units : an evidence based approach, Br Med J Books, 1998. ,
DOI : 10.1002/9780470760215
A pilot study of urokinase therapy in cerebral infarction., Stroke, vol.7, issue.2, pp.135-177, 1976. ,
DOI : 10.1161/01.STR.7.2.135
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy, Journal of Cellular Biochemistry, vol.104, issue.2, pp.77-86, 1987. ,
DOI : 10.7326/0003-4819-104-3-345
Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes, Stroke, vol.23, issue.5, 1992. ,
DOI : 10.1161/01.STR.23.5.632
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset, Stroke, vol.23, issue.5, 1992. ,
DOI : 10.1161/01.STR.23.5.641
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS), JAMA: The Journal of the American Medical Association, vol.274, issue.13, pp.1017-1042, 1995. ,
DOI : 10.1001/jama.274.13.1017
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), The Lancet, vol.352, issue.9136 ,
DOI : 10.1016/S0140-6736(98)08020-9
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, JAMA, vol.282, issue.21, pp.2019-2045, 1999. ,
DOI : 10.1001/jama.282.21.2019
URL : http://jama.jamanetwork.com/data/journals/jama/4714/joc91229.pdf
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, New England Journal of Medicine, vol.359, issue.13, pp.1317-1346, 2008. ,
DOI : 10.1056/NEJMoa0804656
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials, p.37, 2008. ,
Low rates of acute recanalization with 83 ,
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke, Neurology, vol.42, issue.5, pp.976-82, 1992. ,
DOI : 10.1212/WNL.42.5.976
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke, Cerebrovascular Diseases, vol.3, issue.4, pp.269-272, 1993. ,
DOI : 10.1159/000108714
Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial, Stroke, vol.36, issue.7, pp.1432-1438, 2005. ,
DOI : 10.1161/01.STR.0000171066.25248.1d
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke, New England Journal of Medicine, vol.368, issue.10, pp.893-903, 2013. ,
DOI : 10.1056/NEJMoa1214300
URL : http://europepmc.org/articles/pmc3651875?pdf=render
Endovascular Treatment for Acute Ischemic Stroke, New England Journal of Medicine, vol.368, issue.10, pp.904-913, 2013. ,
DOI : 10.1056/NEJMoa1213701
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke, New England Journal of Medicine, vol.368, issue.10, pp.914-923, 2013. ,
DOI : 10.1056/NEJMoa1212793
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke, New England Journal of Medicine, vol.372, issue.1, pp.11-20, 2015. ,
DOI : 10.1056/NEJMoa1411587
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke, New England Journal of Medicine, vol.372, issue.11, pp.1019-1030, 2015. ,
DOI : 10.1056/NEJMoa1414905
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection, New England Journal of Medicine, vol.372, issue.11, pp.1009-1018, 2015. ,
DOI : 10.1056/NEJMoa1414792
t-PA alone in stroke, N Engl J Med. Jun, vol.11, issue.37224, pp.2285-2295, 2015. ,
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke, New England Journal of Medicine, vol.372, issue.24, pp.2296-2306, 2015. ,
DOI : 10.1056/NEJMoa1503780
URL : http://upcommons.upc.edu/bitstream/2117/84030/6/Thrombectomy....pdf
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke, Archives of Neurology, vol.61, issue.3, pp.346-350, 2004. ,
DOI : 10.1001/archneur.61.3.346
Hospital Rates of Thrombolysis for Acute Ischemic Stroke: The Influence of Organizational Culture, Stroke, vol.40, issue.10, 2009. ,
DOI : 10.1161/STROKEAHA.109.559492
American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease ,
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, vol.44, issue.3, pp.870-947, 2013. ,
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, The Lancet, vol.379, issue.9834, pp.2364-2372, 2012. ,
DOI : 10.1016/S0140-6736(12)60738-7
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386494/pdf
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke, JAMA, vol.309, issue.23, pp.2480-2488, 2013. ,
DOI : 10.1001/jama.2013.6959
URL : http://jama.jamanetwork.com/data/journals/jama/927128/joc130067_2480_2488.pdf
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, p.85 ,
Time Is Brain--Quantified, Stroke, vol.37, issue.1, pp.263-66, 2006. ,
DOI : 10.1161/01.STR.0000196957.55928.ab
URL : http://stroke.ahajournals.org/content/strokeaha/37/1/263.full.pdf
Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale, Stroke, vol.40, issue.6, pp.2079-2084, 2009. ,
DOI : 10.1161/STROKEAHA.108.540708
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study, Neurology, vol.55, issue.11, pp.1649-1655, 2000. ,
DOI : 10.1212/WNL.55.11.1649
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, The Lancet, vol.375, issue.9727, pp.1695-1703, 2010. ,
DOI : 10.1016/S0140-6736(10)60491-6
Stroke Thrombolysis: Save a Minute, Save a Day, Stroke, vol.45, issue.4, pp.1053-1058, 2014. ,
DOI : 10.1161/STROKEAHA.113.002910
URL : http://stroke.ahajournals.org/content/strokeaha/45/4/1053.full.pdf
Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target: Stroke Initiative, Stroke, vol.42, issue.10, pp.2983-2989, 2011. ,
DOI : 10.1161/STROKEAHA.111.621342
Reducing in-hospital delay to 20 minutes in stroke thrombolysis, Neurology, vol.79, issue.4, pp.306-313, 2012. ,
DOI : 10.1212/WNL.0b013e31825d6011
Prehospital thrombolysis in acute stroke: Results of the PHANTOM-S pilot study, Neurology, vol.80, issue.2, pp.163-168, 2013. ,
DOI : 10.1212/WNL.0b013e31827b90e5
Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial, The Lancet Neurology, vol.11, issue.5, pp.397-404, 2012. ,
DOI : 10.1016/S1474-4422(12)70057-1
Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative, JAMA, vol.311, issue.16, pp.1632-1672, 2014. ,
DOI : 10.1001/jama.2014.3203
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, vol.42, issue.6, pp.1206-52, 2003. ,
DOI : 10.1161/01.HYP.0000107251.49515.c2
Alcohol Consumption and Risk of Stroke, JAMA, vol.289, issue.5, pp.579-88, 2003. ,
DOI : 10.1001/jama.289.5.579
Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications, Neurology, vol.68, issue.1, pp.39-44, 2007. ,
DOI : 10.1212/01.wnl.0000250341.38014.d2
Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials, Stroke, vol.39, issue.6, pp.1821-1826, 2008. ,
DOI : 10.1161/STROKEAHA.107.505867
Age and National Institutes of Health Stroke Scale Score Within 6 Hours After Onset Are Accurate Predictors of Outcome After Cerebral Ischemia: Development and External Validation of Prognostic Models, Stroke, vol.35, issue.1, pp.158-162, 2004. ,
DOI : 10.1161/01.STR.0000106761.94985.8B
Derivation and validation of a simple risk score for predicting 1-year mortality in stroke, Journal of Neurology, vol.74, issue.10, pp.1376-1383, 2007. ,
DOI : 10.1161/01.STR.29.1.58
Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy, JAMA, vol.292, issue.15, pp.1839-1844, 2004. ,
DOI : 10.1001/jama.292.15.1839
Investigators of the Registry of the Canadian Stroke Network; Stroke Outcomes Research Canada (SORCan) Working Group. IScore: a risk score to predict death early after hospitalization 88 ,
Predicting Clinical Outcomes After Thrombolysis Using the iScore: Results From the Virtual International Stroke Trials Archive, Stroke, vol.44, issue.10, pp.2755-2764, 2013. ,
DOI : 10.1161/STROKEAHA.113.001343